BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11384768)

  • 1. Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probe and the TaqMan technology.
    Pinzani P; Orlando C; Raggi CC; Distante V; Valanzano R; Tricarico C; Maggi M; Serio M; Pazzagli M
    Regul Pept; 2001 Jun; 99(2-3):79-86. PubMed ID: 11384768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue.
    Orlando C; Raggi CC; Bianchi S; Distante V; Simi L; Vezzosi V; Gelmini S; Pinzani P; Smith MC; Buonamano A; Lazzeri E; Pazzagli M; Cataliotti L; Maggi M; Serio M
    Endocr Relat Cancer; 2004 Jun; 11(2):323-32. PubMed ID: 15163307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of somatostatin receptor type 2 gene expression in neuroblastoma cell lines and primary tumors using competitive reverse transcription-polymerase chain reaction.
    Sestini R; Orlando C; Peri A; Tricarico C; Pazzagli M; Serio M; Pagani A; Bussolati G; Granchi S; Maggi M
    Clin Cancer Res; 1996 Oct; 2(10):1757-65. PubMed ID: 9816127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide.
    Orlando C; Raggi CC; Bagnoni L; Sestini R; Briganti V; La Cava G; Bernini G; Tonini GP; Pazzagli M; Serio M; Maggi M
    Med Pediatr Oncol; 2001 Jan; 36(1):224-6. PubMed ID: 11464890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa.
    Casini Raggi C; Calabrò A; Renzi D; Briganti V; Cianchi F; Messerini L; Valanzano R; Cameron Smith M; Cortesini C; Tonelli F; Serio M; Maggi M; Orlando C
    Clin Cancer Res; 2002 Feb; 8(2):419-27. PubMed ID: 11839658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome.
    Raggi CC; Maggi M; Renzi D; Calabrò A; Bagnoni ML; Scaruffi P; Tonini GP; Pazzagli M; De Bernardi B; Bernini G; Serio M; Orlando C
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3866-73. PubMed ID: 11061551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors.
    Briganti V; Sestini R; Orlando C; Bernini G; La Cava G; Tamburini A; Raggi CC; Serio M; Maggi M
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2385-91. PubMed ID: 9815638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of 17q gain and promoter polymorphisms on mRNA expression of somatostatin receptor type 2 in neuroblastoma.
    Simi L; Pinzani P; Raggi CC; Pazzagli M; Orlando C
    Clin Chim Acta; 2007 Sep; 384(1-2):149-54. PubMed ID: 17678886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of positive and negative immunomagnetic isolation followed by real-time RT-PCR for detection of the circulating tumor cells in patients with colorectal cancers.
    Guo J; Xiao B; Zhang X; Jin Z; Chen J; Qin L; Mao X; Shen G; Chen H; Liu Z
    J Mol Med (Berl); 2004 Nov; 82(11):768-74. PubMed ID: 15490093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlative immunohistochemical and reverse transcriptase polymerase chain reaction analysis of somatostatin receptor type 2 in neuroendocrine tumors of the lung.
    Papotti M; Croce S; Macrì L; Funaro A; Pecchioni C; Schindler M; Bussolati G
    Diagn Mol Pathol; 2000 Mar; 9(1):47-57. PubMed ID: 10718213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction.
    Mori M; Mimori K; Inoue H; Barnard GF; Tsuji K; Nanbara S; Ueo H; Akiyoshi T
    Cancer Res; 1995 Aug; 55(15):3417-20. PubMed ID: 7542169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells.
    Xu Y; Song J; Berelowitz M; Bruno JF
    Endocrinology; 1996 Dec; 137(12):5634-40. PubMed ID: 8940394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection.
    Pinzani P; Salvadori B; Simi L; Bianchi S; Distante V; Cataliotti L; Pazzagli M; Orlando C
    Hum Pathol; 2006 Jun; 37(6):711-8. PubMed ID: 16733212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction.
    Gerhard M; Juhl H; Kalthoff H; Schreiber HW; Wagener C; Neumaier M
    J Clin Oncol; 1994 Apr; 12(4):725-9. PubMed ID: 7512130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C; Hu L; Xia L; Li Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
    Zheng HY; Chen Q; Ye YB; Huang WW
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunobead multiplex RT-PCR detection of carcinoembryonic genes expressing cells in the blood of colorectal cancer patients.
    Douard R; Moutereau S; Serru V; Sales JP; Wind P; Cugnenc PH; Vaubourdolle M; Loric S
    Clin Chem Lab Med; 2005; 43(2):127-32. PubMed ID: 15843204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer.
    Buscail L; Saint-Laurent N; Chastre E; Vaillant JC; Gespach C; Capella G; Kalthoff H; Lluis F; Vaysse N; Susini C
    Cancer Res; 1996 Apr; 56(8):1823-7. PubMed ID: 8620499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.